Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma.
Amaury De BarrosJustine AttalMargaux RoquesJulien NicolauJean-Christophe SolElizabeth Cohen-Jonathan-MoyalFranck-Emmanuel RouxPublished in: Journal of neuro-oncology (2019)
We demonstrated that, in addition to the well known issue of incomplete resection, longer delays between surgery and adjuvant treatment is an independent factors of tumor regrowth and a risk factor of poorer outcomes for the patients. To overcome the delay factor, we suggest shortening the usual time between surgery and radiotherapy.
Keyphrases
- minimally invasive
- coronary artery bypass
- early stage
- end stage renal disease
- surgical site infection
- radiation therapy
- risk factors
- locally advanced
- newly diagnosed
- chronic kidney disease
- prognostic factors
- radiation induced
- peritoneal dialysis
- coronary artery disease
- type diabetes
- metabolic syndrome
- insulin resistance
- squamous cell carcinoma
- adipose tissue
- skeletal muscle
- replacement therapy